Similarly, in a rat RA model, administration of soluble TNF receptor I (sTNFRI) as a TNF blocking strategy improved body weight, but also food intake compared to control groups, implying that anti-inflammatory modulation may contribute to bodyweight maintenance by blocking anorexic effects (Granado et al., 2006). The gene discussed is TNF; the disease is rheumatoid arthritis.